Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

11069	Companies
242908	Keywords
171092	Articles
130758	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/06/2025 at 11:00, 11 months 18 days ago

Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
Pentixapharm presents new clinical findings on expanding CXCR4 radiopharmaceutical platform at EANM 2025, demonstrating potential in diagnosis and therapeutics in Primary Aldosteronism and bladder cancer

Pentixapharm CXCR4 Radiopharmaceutical EANM 2025 Clinical Findings
BRIEF

published on 09/26/2025 at 08:05, 11 months 28 days ago

Pentixapharm Advances PentixaTher in AML Trial

Clinical Trial Radiopharmaceuticals Acute Myeloid Leukemia PentixaTher CXCR4-targeting
BRIEF

published on 09/26/2025 at 08:05, 11 months 28 days ago

Pentixapharm fait progresser PentixaTher dans l'essai sur la LAM

Essai Clinique Produits Radiopharmaceutiques Ciblage CXCR4 Leucémie Myéloïde Aiguë PentixaTher
PRESS RELEASE

published on 09/26/2025 at 08:00, 11 months 28 days ago

Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial
Pentixapharm advances PentixaTher to fourth dose level in AML trial, reinforcing safety profile and potential clinical efficacy for CXCR4-targeted radiotherapeutic in high unmet need indication

Pentixapharm CXCR4 Acute Myeloid Leukemia Radiotherapeutic PentixaTher
BRIEF

published on 05/27/2025 at 09:48, 1 year 3 months ago

Pentixapharm Unveils New Clinical Development Strategy

Oncology Pentixapharm CXCR4 Trials Theranostic Strategy Hematologic Malignancies
BRIEF

published on 05/27/2025 at 09:48, 1 year 3 months ago

Pentixapharm dévoile une nouvelle stratégie de développement clinique

Oncologie Pentixapharm Essais CXCR4 Stratégie Théranostique Hémopathies Malignes
PRESS RELEASE

published on 05/27/2025 at 09:43, 1 year 3 months ago

EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
Pentixapharm outlines new clinical development strategy focusing on CXCR4 therapeutic and diagnostic oncology programs, discontinuing PTF301 trial in MZL, preparing new trials in hematologic malignancies and Bladder Cancer

Pentixapharm CXCR4 Oncology Programs Clinical Development Strategy Theranostic Precision
BRIEF

published on 04/25/2025 at 15:44, 1 year 4 months ago

Pentixapharm to Showcase Innovative Antibody GT-008 at AACR 2025

Cancer Therapy Pentixapharm GT-008 Antibody Glycan-Dependent CD24 Targeting
BRIEF

published on 04/25/2025 at 15:44, 1 year 4 months ago

Pentixapharm présentera son anticorps innovant GT-008 à l'AACR 2025

Thérapie Contre Le Cancer Pentixapharm Anticorps GT-008 Glycane-dépendant Ciblage CD24
PRESS RELEASE

published on 04/25/2025 at 15:39, 1 year 4 months ago

Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
Pentixapharm to present novel CD24 antibody GT-008 for solid tumors at AACR 2025, showcasing glycan-dependent mechanism for targeted therapy

Solid Tumors Pentixapharm AACR 2025 GT-008 CD24 Antibody

Accesswire

Published on 09/24/2026 at 13:00, 32 minutes ago

NOA Lithium Provides Update on 2026 Exploration Campaign and Provides Corporate Updates
Published on 09/24/2026 at 13:00, 32 minutes ago

Kalo Gold's Wainikoro Corridor Extends 4.3 Kilometres and Remains Open, with Gold Results to 8.78 g/t Au Along its Length, Vatu Aurum, Fiji
Published on 09/24/2026 at 13:00, 32 minutes ago

Prospect Ridge Stakes Additional Targets at Excalibur Following Successful Initial Drill Program
Published on 09/24/2026 at 12:58, 34 minutes ago

BlackBerry Reports Second Quarter Fiscal Year 2027 Results
Published on 09/24/2026 at 11:00, 2 hours 32 minutes ago

Silver Range Defines Targets at the Drum Property in Utah

View all ACCESSWIRE

EQS Group

Published on 09/24/2026 at 13:25, 6 minutes ago

44 million views later, the musical short "IS IT JUST A GAME?" reveals new clues about the video game PAPmusic Game, coming in 2026
Published on 09/24/2026 at 13:21, 11 minutes ago

Verve Group Media SE: Verve Announces Expected Timetable for Relocation to Ireland and Proposed Suspension of Trading for One Day
Published on 09/24/2026 at 12:40, 51 minutes ago

Driving Global Growth: FAW TRUCKS Chairman on European Expansion, Capital Discipline and TCO Strategy
Published on 09/24/2026 at 12:35, 56 minutes ago

Hitachi Solutions achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award.
Published on 09/24/2026 at 12:35, 56 minutes ago

Bybit Unveils "Make Your Move" as New Global Brand Campaign for The New Financial Platform

Les Echos

Published on 09/24/2026 at 08:00, 5 hours 32 minutes ago

Neoen launches construction of 3 solar farms and a wind farm in France, with a total capacity of 101 MW
Published on 09/24/2026 at 08:00, 5 hours 32 minutes ago

Neoen lance la construction de trois parcs solaires et un parc éolien en France pour une capacité totale de 101 MW
Published on 09/24/2026 at 07:30, 6 hours 2 minutes ago

Gimv rondt met succes private plaatsing van een obligatie af voor een bedrag van EUR 150 miljoen
Published on 09/24/2026 at 07:30, 6 hours 2 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Published on 09/24/2026 at 07:30, 6 hours 2 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million

View all LES ECHOS COMFI WIRE